Vanguard Fiduciary Trust
VRCA icon

Vanguard Fiduciary Trust’s Verrica Pharmaceuticals VRCA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Buy
70,173
+5,072
+8% +$31.6K ﹤0.01% 3329
2026
Q1 		$344K Buy
+65,101
New +$417K ﹤0.01% 3339

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's VRCA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Verrica Pharmaceuticals (VRCA) stake by 7.8% in Q2 2026, buying an estimated $31.6K and bringing the position to 70,173 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #3329.

Vanguard Fiduciary Trust first reported a position in VRCA in Q1 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Vanguard Fiduciary Trust held 70,173 shares of Verrica Pharmaceuticals worth $429K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 5,072 Verrica Pharmaceuticals shares in Q2 2026, an estimated $31.6K.
  • Verrica Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3329 holding.
  • Vanguard Fiduciary Trust first reported a position in Verrica Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.